C4 Therapeutics Cash Flow Statement (2019-2025) | CCCC

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -10.09M-10.02M-11.91M-10.79M-21.84M-21.80M-20.97M-22.58M-24.68M-15.66M-31.62M-26.88M-31.96M-27.41M-34.78M-35.92M-27.04M-34.75M-28.36M-17.72M-24.67M-34.57M-26.32M-26.02M-32.17M
Depreciation and Depletion 0.42M0.42M0.42M0.36M0.45M0.39M0.33M0.32M0.30M0.43M0.41M0.52M0.55M0.46M0.45M0.13M0.38M0.30M0.36M0.36M0.36M0.42M0.38M
Share-based Compensation 0.63M0.73M0.12M0.16M0.44M2.72M3.85M5.23M6.09M6.35M8.94M8.15M6.01M6.92M6.25M6.42M8.20M6.36M6.21M6.38M8.83M8.23M5.51M4.99M4.59M
Gains from Investment Securities 2.31M3.14M2.54M5.95M6.15M20.13M44.07M
Asset Writedowns and Impairment 10.73M
Non-cash Items 4.80M11.37M102.64M0.53M0.97M1.12M1.36M1.67M
Cash from Operations -10.30M-16.67M-14.59M-14.40M-21.59M-24.93M-18.00M-18.36M-25.67M-26.60M-22.20M-28.02M-29.13M-33.12M-19.00M-30.71M-24.01M-18.12M-4.97M-24.13M-17.93M-33.28M-12.06M-31.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.29M0.30M0.30M0.20M0.31M0.32M0.33M-1.68M-0.85M1.18M1.71M1.50M1.50M1.52M1.53M1.55M1.56M1.58M1.60M1.61M1.63M1.65M1.67M1.69M
Depreciation & Amortization (CF) 0.42M0.42M0.42M0.42M0.36M0.45M0.39M0.33M0.32M0.30M0.43M0.41M0.52M0.55M0.46M0.45M0.43M0.45M0.45M0.44M0.48M0.46M0.61M0.46M
Change in Working Capital
Change in Receivables 2.03M-1.30M5.23M-4.41M0.34M-0.83M2.56M-1.37M0.87M-3.94M-0.06M-0.22M-0.01M-0.94M0.50M-0.53M11.30M1.80M-12.43M9.17M-7.24M4.93M-5.83M4.34M
Change in Account Payables 1.16M-2.10M2.56M-0.59M0.60M-1.97M0.63M-0.60M0.76M-1.15M0.59M-1.69M-1.08M-0.14M1.08M-0.84M0.17M0.18M-0.71M0.59M-0.18M-0.65M1.53M-0.89M
Change in Accured Expenses 1.99M-1.30M0.67M3.78M-0.60M-3.67M3.98M1.93M2.13M-3.77M3.68M2.48M2.69M-3.67M0.54M-0.73M5.18M-7.66M-1.75M4.17M3.98M-6.73M0.63M-2.02M
Investing Activities
Capital Expenditures -0.07M0.18M-0.11M0.28M0.29M0.72M0.45M0.11M0.17M3.10M0.74M1.49M0.59M0.36M0.60M0.16M0.20M-0.01M-0.00M0.30M
Change in Acquisitions & Divestments 63.76M114.99M94.50M54.08M86.11M72.39M65.67M78.33M67.06M65.56M64.15M90.27M69.98M54.35M55.72M68.71M54.45M54.77M60.79M51.18M
Cash from Investing Activities -0.20M-0.18M-103.83M-32.32M-54.17M-61.73M32.43M-100.63M-59.41M-4.00M33.23M19.91M9.28M53.53M15.15M57.73M31.95M-53.40M-11.71M0.16M13.67M29.12M38.92M4.09M
Financing Activities
Other financing activities -0.00M0.18M-0.29M0.22M0.15M0.10M0.00M0.26M-0.00M0.08M0.30M0.00M0.11M0.16M
Change in Capital Stock
Shares Issued 0.07M0.16M0.08M0.53M194.31M0.17M0.54M0.87M0.75M0.26M0.26M0.21M0.05M0.06M0.00M0.52M0.14M0.01M0.11M0.11M
Shares Repurchased -0.01M0.09M-0.02M0.09M0.02M0.11M0.09M0.15M0.02M
Preferred Shares Issued 4.50M
Misc.
Cash from Financing Activities 0.08M0.16M152.22M2.50M194.05M-0.15M170.50M0.58M0.47M0.48M0.26M0.36M0.05M-0.68M-0.75M-10.75M57.67M34.58M0.14M10.51M0.11M-0.05M7.77M
Change in Cash -10.42M-16.69M33.80M-44.22M118.29M-86.81M184.93M-118.40M-84.62M-30.12M11.29M-7.75M-19.80M19.72M-4.59M16.27M65.61M-36.93M-16.55M-13.46M-4.15M-4.21M26.86M-19.35M
Beginning Cash Balance 100.97M100.97M90.55M73.86M107.65M251.75M181.73M96.21M281.15M160.74M76.12M46.00M57.30M49.55M29.75M49.48M44.71M60.98M126.59M89.66M73.11M59.65M55.50M51.29M78.16M
Free Cash Flow -10.23M-16.85M-14.48M-14.68M-21.88M-25.66M-18.45M-18.36M-25.78M-26.77M-25.29M-28.76M-30.62M-33.71M-19.36M-31.31M-24.17M-18.12M-5.17M-24.12M-17.93M-33.28M-12.06M-31.51M
Net Cash Flow -10.42M-16.69M33.80M-44.22M118.29M-86.81M184.93M-118.40M-84.62M-30.12M11.29M-7.75M-19.80M19.72M-4.59M16.27M65.61M-36.93M-16.55M-13.46M-4.15M-4.21M26.86M-19.35M